Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)

This study has been completed.
Information provided by:
Charite University, Berlin, Germany Identifier:
First received: January 3, 2006
Last updated: January 27, 2009
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)